(Q34196393)

31 July 2017

1 reference

title

Role of the sympathetic nervous system in cardiac remodeling in hypertension (English)

1 reference

31 July 2017

Iaccarino G

1

1 reference

31 July 2017

Barbato E

2

1 reference

31 July 2017

Cipoletta E

3

1 reference

31 July 2017

Fiorillo A

4

1 reference

31 July 2017

Trimarco B

5

1 reference

31 July 2017

publication date

1 January 2001

1 reference

Clinical and Experimental Hypertension

31 July 2017

published in

1 reference

31 July 2017

volume

23

1 reference

31 July 2017

issue

1-2

1 reference

31 July 2017

page(s)

35-43

1 reference

The evidence for a pathophysiologic significance of the sympathetic overactivity in hypertension

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100001195

Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100001195

Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100001195

Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100001195

Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100001195

Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100001195

Tissue distribution of beta 3-adrenergic receptor mRNA in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100001195

Action potential shortening through the putative beta4-adrenoceptor in ferret ventricle: comparison with beta1- and beta2-adrenoceptor-mediated effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100001195

Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100001195

Targeting Gbeta gamma signaling in arterial vascular smooth muscle proliferation: a novel strategy to limit restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100001195

Mechanism of beta-adrenergic receptor desensitization in cardiac hypertrophy is increased beta-adrenergic receptor kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100001195

Transgenic Galphaq overexpression induces cardiac contractile failure in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100001195

Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100001195

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100001195

Mechanisms of membrane-receptor regulation. Biochemical, physiological, and clinical insights derived from studies of the adrenergic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100001195

Epidemiology of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100001195

Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100001195

Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100001195

Participation of endogenous catecholamines in the regulation of left ventricular mass in progeny of hypertensive parents

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100001195

Effects of angiotensin II type 1 receptor blockade and angiotensin-converting enzyme inhibition on cardiac beta-adrenergic signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100001195

Adverse effects of chronic endogenous sympathetic drive induced by cardiac GS alpha overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100001195

Apoptosis of cardiac myocytes in Gsalpha transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100001195

Adenylylcyclase increases responsiveness to catecholamine stimulation in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100001195

Both Gs and Gi proteins are critically involved in isoproterenol-induced cardiomyocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100001195

Cardiac-specific overexpression of the alpha(1) subunit of the L-type voltage-dependent Ca(2+) channel in transgenic mice. Loss of isoproterenol-induced contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100001195

Identification of an essential signaling cascade for mitogen-activated protein kinase activation by angiotensin II in cultured rat vascular smooth muscle cells. Possible requirement of Gq-mediated p21ras activation coupled to a Ca2+/calmodulin-sensi

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100001195

Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100001195

21 January 2018

Identifiers

DOI

10.1081/CEH-100001195

1 reference

31 July 2017

1 reference